Evidence map›Paper›PMID 37969149›Full record

ArticleJournal of medical physics

Investigation of TG-43 Dosimetric Parameters for

Musa Joya, Hassan Ali Nedaie, Ghazale Geraily, Hadi Rezaei, Awaz Bromand, Mahdi Ghorbani, Peyman Sheikhzadeh

Open access · diamondAbstract read
In one paragraph

Article in Journal of medical physics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Musa JoyaDepartment of Medical Physics and Biomedical Engineering, Faculty of Medicine, Tehran, Iran.
Hassan Ali NedaieDepartment of Medical Physics and Biomedical Engineering, Faculty of Medicine, Tehran, Iran.
Ghazale GerailyDepartment of Medical Physics and Biomedical Engineering, Faculty of Medicine, Tehran, Iran.
Hadi RezaeiDepartment of Medical Physics and Biomedical Engineering, Faculty of Medicine, Tehran, Iran.
Awaz BromandDepartment of Physics, Ghor Institute of Higher Education, Ghor, Afghanistan.
Mahdi GhorbaniDepartment of Biomedical Engineering and Medical Physics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Peyman SheikhzadehDepartment of Medical Physics and Biomedical Engineering, Faculty of Medicine, Tehran, Iran.
Tehran University of Medical Sciences · IRImam Khomeini Hospital · IRShahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: According to the revised Task Group number 43 recommendations, a brachytherapy source must be validated against a similar or identical source before its clinical application. The purpose of this investigation is to verify the dosimetric data of the high dose rate (HDR) BEBIG Materials and Methods: The HDR Results: The dose rate constant was obtained as 1.098 ± 0.003 cGy.h - Conclusion: The results of this study suggest that the GATE Monte Carlo code is a valid toolkit for benchmarking brachytherapy sources and can be used for brachytherapy simulation-based studies and verification of brachytherapy treatment planning systems.

Indexed as

BEBIG 192Ir sourceGATE codeMonte Carlo simulationTG-43U1 report

Identifiers

PMID37969149
PMCPMC10642593
OpenAlexW4386902166

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.